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Summary 
Macrophages from mice bearing large D1-DMBA-3 mammary tumors have a decreased capacity 
to kill tumor targets.  This effect is due to an impaired ability to produce nitric oxide (NO) 
in response to lipopolysaccharide (LPS) stimulation. Here we report that the DA-3 tumor cell 
line, derived from the in vivo adenocarcinoma D1-DMBA-3, produces a factor that inhibits both 
NO production/release and cytotoxicity of LPS-activated peritoneal exudate macrophages (PEM). 
However, other complex macrophage functions such as phagocytosis, superoxide production, 
mitochondrial dehydrogenase activity, and synthesis of proteins were not reduced by this factor. 
The NO inhibitor has been found to be lipid in nature. Lipid extracts from DA-3 cell culture 
supernatants were purified by repeated silica gel column chromatography. The active molecule 
was unambiguously characterized as phosphatidyl serine (PS) by fast atom bombardment tandem 
mass spectrometry. Preliminary results indicate a lack of induced NO synthase (iNOS) activity 
in the lysates of LPS-activated PEM pretreated with PS. The ubiquity of PS in the inner leaflet 
of biological membranes and its NO inhibitory property, suggest that this phospholipid may 
be one of the long elusive molecules responsible for regulating physiological levels of NO in 
the host and hence preventing cellular dysfunction and/or tissue damage. Furthermore, the possible 
overexpression and shedding of PS by DA-3 tumor cells may represent a novel mechanism to 
impair macrophage cytotoxicity, a host function that contributes to the protection against developing 
neoplasms. 
U 
'pon activation with a variety of stimuli, macrophages 
produce factors that lead to lysis of tumor targets. This 
host defense mechanism has been shown to be mediated by 
the participation of one or more molecules, which include 
TNF-ot,  oxygen-reactive intermediates,  and  nitric  oxide 
(NO) t (1). We previously have shown that peritoneal exu- 
date macrophages (PEM) from mice bearing large mammary 
tumors have an impaired capacity to kill xenogeneic, allogeneic, 
syngeneic, and autologous tumor targets (1-3). Recently we 
have found that  PEM  from these tumor bearers produce 
TNF-a,  IL-1, and H202 at levels comparable or higher to 
1  Abbreviations used in this paper: FAB, fast atom bombardment; GC-MS, 
gas chromatography-mass  spectrometry; iNOS, induced nitric oxide 
synthase; MTT, (3-[4,5-dimethylthiazol-2-yl]-2,5  diphenyltetrazolium 
bromide); m/z, mass-to-charge  ratio; NADPH, B-nicotinamide  adenine 
dinucleotide phosphate, reduced form); NGMMA, NG-monomethyl-t  - 
arginine, monacetate; NO,  nitric oxide; NO2-;  nitrite anion; PC, 
phosphatidyl choline; PEM, periotoneal exudate macrophage; PG, 
phosphatidyl  glycerol;  PLC, phospholipase  C; PS, phosphatidyl  serine; SM, 
sphingomyelin. 
those of PEM from normal mice (3). However, they display 
a depressed capacity to produce NO, an important cytostatic 
factor for macrophages (4,  5). 
In previous studies, we have found that the DA-3 tumor 
cells synthesize a variety of factors that modulate the host 
immune response of tumor-bearing mice. Thus, we sought 
to investigate whether a tumor-derived product was respon- 
sible for the inhibited NO production observed. We now 
describe that supernatants of the DA-3 tumor cell line re- 
lease a factor that inhibits, in a dose-dependent fashion, NO 
production and the cytotoxic activity of PEM derived from 
normal mice. This inhibitory molecule has been character- 
ized by enzymatic degradation and mass spectrometry (MS) 
analysis  as phosphatidyl serine (PS)  (6,  7). 
Materials and Methods 
Mice and Tumor Cells.  BALB/c  mice are maintained by brother- 
sister matings in our laboratory at the University of Miami School 
of Medicine. The DA-3 tumor cell line was derived from the in 
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The DA-3 cells produce tumors in BALB/c mice and express the 
same tumor-associated Ags on their surfaces as the parent tumor 
cells. The cell line is grown in RPMI-1640-supplemented media 
with 5% FCS,  100 U  penicillin, 100 #g/ml streptomycin, 5  x 
105 M  2-ME,  2 mM r-glutamine,  1% nonessential amino acids, 
1% essential amino adds, and 1% sodium pyruvate (all from GIBCO 
BRL, Gaithersburg, MD), and maintained by serial passage. These 
cells are free of endotoxin as ascertained  by routine assays with 
Limulus amebocyte lysate (Pyrogent  |  plus;  Whittaker M.A. Bi- 
oproducts, Inc., Walkersville, MD). The metastatic 410.4 and non- 
metastatic 168 cell lines were derived from a spontaneously arising 
mammary tumor in a BALB/C fCaH mouse (9) and cultured in 
Waymouth medium (GIBCO BRL) supplemented with 10% FCS. 
The human cell lines, A375 melanoma, squamous cell carcinoma 
A431, and a normal human epidermal keratinocyte (NHEK), were 
obtained from American Type Culture Collection (Rockville, MD) 
and cultured as indicated (10). 
Reagents.  The culture medium used in the experimental assays 
was  RPMI-1640  supplemented  with  100  /zg/ml  streptomycin, 
5  x  10 -5 M  2-ME,  2mM r-glutamine,  1%  nonessential amino 
acids,  1%  essential  amino acids,  1%  sodium pyruvate (all from 
GIBCO BRL), and 10% endotoxin-free FCS (Hyclone Laborato- 
ries, Logan, UT). LPS (Escherichia coli 055:B5) from Difco Labora- 
tories (Detroit, MI) was used as indicated. Bovine brain PS extract 
(Type III: Folch Fraction III), phosphatidyl glycerol ([PG] from 
egg yolk lecithin), phosphatidyl choline ([PC] from bovine brain), 
sphingomyelin ([SM] from chicken egg yolk), trypsin, proteinase 
K  NADPH (B-nicotinamide adenine dinucleotide phosphate re- 
duced  form),  FAD  (flavin  adenine  dinucleotide),  PMA,  fer- 
ricytochrome c from bovine heart, superoxide dismutase from bo- 
vine liver, r-lactic dehydrogenase (type XVII from bovine heart), 
staphylococcal enterotoxin B (SEB) from Staphylococcus aureus, and 
MTT (3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bro- 
mide) were purchased from Sigma Chemical Co. (St. Louis, MO). 
DNase, pepstatin A, chymostatin, aprotinin, PMSF, and DTT (di- 
thiothreitol) were obtained from Boehringer Mannheim  (Indi- 
anapolis, IN). Synthetic 1-stearoyl-2-oleoyl-sn-glycero-3-[phospho- 
t-serine] was obtained from Avanti Polar Lipids,  Inc.  (Alabaster, 
AL). Molybdenum (VI) oxide (MOO3), zinc chloride, and resor- 
cinol were purchased from Aldrich Chemical Co., Inc. (Milwaukee, 
WI). HPLC grade chloroform and methanol were purchased from 
Baxter Diagnostics Inc.  (McGraw Park,  IL). NCmonomethyl-r  - 
arginine  monoacetate (NCMMA)  and t-arginine  were obtained 
from Calbiochem-Novabiochem Corp. (La JoUa, CA). BH4 ([6R]- 
5,6,7,8-tetrahydro-t-biopterin dihydrochloride)  was purchased from 
ICN Biomedicals  Inc.  (Costa Mesa,  CA).  Sodium pyruvate was 
obtained from JRI-I Biosciences (Lenexa, KS). Murine r-IFN-qr was 
purchased from Genzyme Corp.  (Cambridge,  MA). 
Macrophage Cultures.  Normal mice were injected with 1 ml i.p. 
of thioglycollate (Difco Laboratories). On day 4, the PEM were 
obtained by peritoneal lavage with 10 ml ice-cold RPMI-1640/mice. 
Peritoneal cells were washed twice and resuspended in supplemented 
RPMI-1640 media. The adherent population was obtained following 
the plastic-adherent technique described by Pennline (11). This pro- 
cedure provides a population consisting of >95% macrophages as 
determined by staining with Diff-Quick differential  stain (Baxter 
Diagnostics Inc.) and nonspecific esterase staining (Sigma Chem- 
ical Co.). Viability of cells was routinely >95%  by trypan blue 
exclusion.  PEM were seeded into 96-well,  flat-bottom microtiter 
plates (Costar Corp., Cambridge, MA) at a cell density of 1.5  x 
10S/microtiter well. 
Collection and Initial Treatments of DA-3 Cell Supernatants.  Cells 
of the DA-3  line (10S/ml)  were continually cultured with  sup- 
plemented RPMI-1640 and supernatants were collected 3 d after 
passage, centrifuged at 400 g for 10 min to remove cellular compo- 
nents, passed through a 0.45-/~m filter (Millipore Corp., Bedford, 
MA), and stored at  -20~  until use. Aliquots of DA-3 superna- 
tants were heated at 100~  for 20 min, or treated with either trypsin 
(10 #g/ml), proteinase K (0.5 mg/ml), or DNase (100 U/ml) over- 
night at 37~  Filtered  DA-3 supernatants were extracted twice 
with a threefold volume of HPLC-grade chloroform-methanol (2:1, 
vol/vol). The organic phases were combined and concentrated in 
vacuo, and then transferred to 5-ml glass vials. Samples were taken 
to complete dryness under a stream of nitrogen. The film of the 
crude lipid  extract contained in the glass vial was weighted and 
then dispersed in RPMI-1640 by sonication for 7 rain in a bath- 
type sonicator.  The lipid suspension was then sterilized by heating 
(100~  20 min) and then resonicated for 7 min before use in 0.2- 
ml cultures. Before the biological assay, traces of methanol and chlo- 
roform present in the aqueous phase were removed with a rotary 
evaporator in vacuo. This phase was then filtered with a 0.45-/zm 
filter and subsequently sterilized by heating at 100~  for 20 rain 
before use. 
Nitrite (NO:)  Determination.  PEM  from normal mice were 
preincubated for 24 h in the presence or absence ofinhibitors. After 
this time, the macrophages were washed twice and further incubated 
for 24 h  without or with LPS to elicit  the production of NO. 
In some experiments IFN-y (500  U/ml)  or SEB at  300 #g/ml 
were used instead of LPS as activators.  Nitrite concentration in 
the cell-free  macrophage  supernatants  served  as  a  reflection of 
NO production  and  was  measured  by  the  colorimetric Griess 
reaction as described  by Stuehr and Nathan (12). Briefly, 100 #1 
of sample  aliquots  were mixed with  100 #I  of Griess  reagent 
(1% sulfanilamide; 0.1% N-[1-naphthyl]ethyl-enediamine dihydro- 
chloride and 2% H3PO4) and incubated at room temperature for 
10 min. The absorbance  at 550 nm was measured in a microplate 
reader (BioWhittaker, Inc., Walkersville, MD). NOc  levels were 
determined using NaNO2 as a standard,  and double-distilled  H20 
as a blank. 
Fractionation of Lipids Extracted from the DA-3 Cell Supernatants 
and Assessment  of their NO Inhibitory Property.  After concentra- 
tion of dryness, the crude lipids were resuspended  in chloroform 
and a preliminary separation  was carried out by silica gel (230-400 
mesh; Association for Standard Test Methods [ASTM], American 
Scientific Products [ASP], McGauss Park, IL) column chromatog- 
raphy sequentially fractionated with HPLC grade chloroform, ace- 
tone, and methanol (13). 5 ml of crude fractions were collected, 
dried under nitrogren, and dispersed in RPMI-1640 by sonication. 
The collected fractions were sterilized  and preincubated at a con- 
centration of 130 #g/ml with PEM from normal mice (1.5  x  105 
macrophages/0.2 ml) for 24 h. After this time, the macrophages 
were stimulated with LPS (10 #g/ml) for an additional 24 h, and 
the formation of NO2- was measured.  The fractions were moni- 
tored by TIC  (250-#m layer flexible plates for silica gel TLC; 
Whatman  Laboratory Products,  Clifton,  NJ),  developed  with 
chloroform-methanol-acetic acid-water  (65:15:10:4, vol/vol), and 
visualized with either iodine vapors, resorcinol reagent (14), or mo- 
lybdenum blue reagent (15). 
Purification of the Active Lipid Fractions.  The active fraction (meth- 
anol eluate) was concentrated in vacuo at 40~  resuspended  in 
chloroform-methanol (95:5), charged on a silica gel column as above, 
and  successively eluted  with chloroform-methanol (9:5,  80:20, 
0:100) mixtures (16). 5-ml fractions were collected and the separa- 
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chloroform-methanol-acetic acid-water (65:15:10:4,  vol/vol). The 
chromatogram was visualized with molybdenum blue. The col- 
lected fractions were stored at -20~  until used in the experimental 
procedures. 
HPLC Analysis.  The purified fraction from the second chro- 
matographic separation containing the inhibitory activity (fraction 
46), was dried under nitrogen and resuspended in 1 ml of chloro- 
form. This solution (15/~1) was injected into a HPLC system (Di- 
onex Corp., Sunnyvale,  CA) using a 3.9 mm  x  30 cm/~Porasil  TM 
(Waters Chromatography Div., Milford, MA) with a mobile phase 
of acetonitrile-methanol-85 % phosphoric acid (390:5:4.5,  vol/vol) 
flowing at 2.0 ml/min. UV detection was monitored at 205 nm (17). 
Digestion of Fraction 46 with Phosloholipase C (PLC).  The diges- 
tion of phospholipids with PLC from Bacillus cereus has been de- 
scribed elsewhere (18). Briefly, fraction 46 (5 mg) and SM (3 mg) 
were mixed with 0.2 M  phosphate buffer (pH 7.0, 0.5 ml) con- 
taining 0.001  M  2-ME, 0.0004  M  zinc chloride, and  1 mg PLC 
from B. cereus (Fluka Chemie AG, Buchs,  Switzerland) in the same 
buffer (0.5 ml). After the mixture was shaken vigorously for 2 h 
at 37~  it was extracted three times with diethyl ether (4-ml por- 
tions).  The ether layer was dried over anhydrous sodium sulfate 
before it was evaporated in a stream of nitrogen. The resulting lipids 
were separated by TIC (250-#m layer flexible plates for silica gel 
TLC; Whatman Laboratory Products) with hexane-diethyl ether 
(50:50,  vol/vol) as solvent system and sprayed with iodine vapors. 
The bands were scraped from the plates and eluted with methanol. 
The resulting solution was evaporated with a stream of nitrogen, 
resuspended in RPMI-1640, and sterilized in the same way as frac- 
tion 46. 
Transesterification of Fraction 46.  A 10-/xg portion of fraction 46 
was dissolved  in a 1-N solution of sodium methoxide in absolute 
methanol (Aldrich Chemical Co.). After 2 h, the reaction mixture 
was dried under a stream of nitrogen. The liberated fatty acid methyl 
esters were then dissolved in 20/zl N-methyl-trimethylsilyltrifluoroa- 
cetamide (MSTFA;  Regis Chemical Co.,  Morton  Grove, IL) to 
which was added 2/~1 of 10% 2,4,6-trimethylpyridine in chloro- 
form to trimethylsilylate-free  hydroxyl groups. After 15 min at 60~ 
the silylation reaction mixture was cooled and used directly for 
gas chromatography (GC-MS) analysis. 
Mass Spectrometry.  Fast atom bombardment (FAB) mass spectra 
were acquired on a HX-110 double focusing mass spectrometer (Jeol 
Ltd., Peabody, MA) operating in the negative ion and positive ion 
mode. For the negative ion mode analysis, samples were prepared 
by mixing 1 #1 of the sample solution (0.5-1/zg/#l) with a matrix 
solution composed of glycerol/15-crown-5/18-crown-6 (1  +  0.5 
+  0.5 #1) containing N-octyl nicotinium bromide (1/zl of 0.5/zg//~l 
methanol) on the probe tip. Glycerol (1-2/zl) was used as matrix 
for the positive ion mode analysis. After introduction of the probe 
through the vacuum lock, ions were produced by bombardment 
with a beam of 6 keV Xe atoms. The accelerating voltage was 10 
kV and the resolution was set to 1,000.  For collisionally activated 
dissociation  tandem MS (CAD-MS/MS), helium was used as a col- 
lision gas in a cell located in the first field-free region. The helium 
pressure was adjusted to reduce the absorbance of the precursor 
ion by 50%. A data system (model DA-5000, Jeol) generated linked- 
scans at a constant B/E ratio. The instrument was scanned from 
zero to 1,500 mass units in 45 s. Data presented were from a single 
scan. 
GC-MS was performed on a double focusing mass spectrometer 
(model AXS05; Jeol) interfaced to a gas chromatograph (model 
5890; Hewlett-Packard, Palo Alto, CA) via a heated inlet. A 15 m 
x  0.32 mm id capillary column (model DB-1701; J & W  Scientific, 
Folsom, CA) was used for the analysis. The temperature program 
was initiated at 100~  and held for 2 min. At a rate of 25 ~ per 
min the temperature was increased  to 200~  and then at 5 ~ per 
min at 260~  The injector and interface temperature were 260 ~ 
and 280 ~ respectively. Electron impact ionization at 30eV was em- 
ployed. 
Macrophage Cytotoxicity  Assay.  Cytotoxicity was determined 
by the  MTT  method  (19).  Briefly,  purified  PEM  from normal 
mice (1.5  x  105 cells/well) were first incubated in either medium 
alone,  DA-3 cell supernatants, different concentrations of the ac- 
tive fraction 46, or as indicated in Results.  After 24 h,  superua- 
tants of macrophage cultures were discarded,  and the cells were 
washed  twice  with  warm  RPMI-1640.  Experimental  cultures 
were stimulated with 10 #g/ml LPS for an additional 24 h. The 
cultures were washed with RPMI-1640 before addition and coculture 
with DA-3 targets (104/well)  for 18 h.  MTT (5 mg/ml) in PBS 
was added to each well, and the microplates were further incubated 
at 37~  for 4 h. Supernatants were then discarded  and 200 #1 of 
acidified isopropanol (0.04  N  HC1 in isopropanol) were added to 
the cultures and mixed thoroughly to dissolve the blue crystals of 
formazan. Formazan quantification was performed using an auto- 
matic plate reader (BioWhittaker, Inc.). The absorbance was mea- 
sured at 570 nm. Data were expressed as mean absorbance value 
(OD) of triplicate samples +_ standard error of the mean. Percent- 
specific cytotoxicity (% C) was calculated as follows: 100  -  [(OD 
ofeffectors +  targets)  -  (OD ofeffectors)/OD of targets]  x  100. 
Cell Viability.  Monolayers of PEM were preincubated for 24 h 
in  the presence or absence of PS.  The cultures were vigorously 
washed with RPMI-1640 and further incubated at 37~  for 4 h 
with 200/~1 of 5 mg/ml MTT in PBS. Formazan formation was 
assayed as indicated above. 
Superoxide (02-) Assay.  Superoxide generation was measured 
as the superoxide dismutase-inhibitable reduction of ferricytochrome 
c  as  described  by  Pick  and  Mizel  (20).  Briefly,  macrophage 
monolayers (1.5  x  105 cells) preincubated or not with PS for 24 h 
were washed twice with  RPMI and then  stimulated with LPS 
(10/xg/ml) and PMA (100 ng/ml) for 24 h. After this time, the 
cell cultures were washed with warm HBSS without phenol red 
to completely remove the red coloration of the RPMI. Macrophage 
monolayers were incubated for I h with 100 #1 of reaction solution 
containing 160/~M ferricytochrome c in the HBSS without phenol 
red at pH 7.4. The amounts of O2- production per well was cal- 
culated from the following formula: nmol Oz-  per well  =  (ab- 
sorbance at 550 nm/6.3)  x  100. The specificity of the reaction 
was checked by the addition of superoxide dismutase (300 U/ml) 
which inhibited at least 90% of the stimulation. The absorbance 
at 550 nm was measured in a microplate reader (BioWhittaker,  Inc.). 
Phagocytosis.  Coverglass slips were placed on  the bottom of 
17-mm plastic wells (24-well cell culture cluster,  Costar Corp.) to 
which 3  x  105 PEM from normal mice in I ml RPMI were added 
per well and incubated at 37~  for adherence. Monolayers of ad- 
herent macrophages were cultured for 24 h with medium alone 
or medium with PS (160/zg/ml). The macrophage cultures were 
washed twice with RPMI and further incubated for 30 min with 
3  x  107 zymosan particles (Sigma Chemical Co.) in 1 ml culture 
medium supplemented with 10/xg/ml LPS.  After this period of 
time, cell monolayers were washed, fixed with 2% paraformalde- 
hyde,  and  permeabilized  with  methanol.  The  coverslips  were 
mounted on a glass slide and the number of zymosan particles phago- 
cytosed by PEM were determined using an oil immersion objec- 
tive. At least 100 cells were counted to determine a mean number 
of phagocytosed particles. 
Laser Scanning Confocal Microscotv.  Experimental PEM were also 
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a laser scanning device  (MultiProbe  2001;  Molecular Dynamics, 
Sunnyvale, CA) using the 488-nm wavelength of the argon/krypton 
emission lines.  The confocal laser scanning images were collected 
and recorded at 0.6-/~m increments. The image processing was per- 
formed on a computer (Silicon  Graphics, Mountain View,  CA), 
and grey or pseudo colorizations were overlayed on the transmitted 
light image and the refracted light image respectively.  Black and 
white pictures were taken by a 35-mm camera (Screen Star, Sun- 
nyvale,  CA). 
Protein Determination.  Control and PS pretreated macrophage 
monolayers were washed twice with RPMI and then incubated 
at 37~  for 24 h with culture medium plus LPS (I0 #g/ml). After 
removal of the culture supernatants,  adherent cells were washed 
twice and lysed with 0.5 N  NaOH. Protein concentration in the 
lysates was determined by the method of Lowry (21) using a pro- 
tein assay kit (Sigma Chemical Co.). Optical absorbance was mea- 
sured at 570 nm. 
Measurements of II~lol  and 11_,6.  PEM  experimental  culture 
supernatants from triplicate wells  were pooled and IL-lc~ protein 
concentrations were measured quantitatively by ELISA (Inter Test- 
I~X Mouse IL-l-c~ ELISA kit; Genzyme Corp.). Similarly,  IL-6 
was measured using a murine IL-6 ELISA kit (Endogen Inc., Boston, 
MA). 
Kinetics of the lnhibitory Aaivity of  PS on LPS-activated  PEM.  Mac- 
rophages were preincubated with 160 #g/ml PS at 37~  for time 
periods of 2, 4, 6, 8, and 18 h. Subsequently, the cells were washed 
twice with  RPMI and further incubated for 18 h  with culture 
medium containing  10/zg/ml  LPS.  NO2-  concentration  in  the 
cell-flee macrophage supernatants was measured as described above. 
Another experimental group consisted ofmacrophage cultures cocul- 
tured for 18 h with 10/zg/ml LPS and 160 #g/ml PS. The effect 
of PS on the nitrite production of LPS-activated macrophages was 
assayed by adding 160/zg/ml PS to LPS-activated macrophages 2, 
4, and 6 h after activation. PS untreated macrophages were used 
as controls for each experimental group. 
Reversibility of the Inhibitory Activity of PS on the Production of NO 
PEM.  Monolayers of PEM were preincubated at 37~  with 
medium alone or medium supplemented with  160/zg/ml PS for 
a period of 24 h. After removal of PS, macrophage monolayers were 
washed twice with RPMI, fresh medium was added, and activa- 
tion followed immediately thereafter (zero time) with  10/zg/ml 
LPS for 18 h  or after 24 or 48 h of incubation at 37~  Macro- 
phage supernatants were analyzed for their content of NO2-. 
Preparation of Macropkage Cytosol and Measurement of lndudble NO 
Synthase (iNOS) Activity.  This experiment was carried out as de- 
scribed by Bogdan et al. (22). LPS-activated PEM untreated (con- 
trol) or PS pretreated were resuspended in culture medium and 
pelleted by centrifugation  at 4~  and resuspended again in  1X 
PBS and counted in trypan blue. The cells (8.25  x  107) were then 
repelleted and lysed by three cycles of freezing and thawing in  1 
ml of lysis buffer (40 mM Tris/HC1, pH 8, 5 #g/ml pepstatin A, 
1 /zg/ml chymostatin,  5/zg/ml  aprotinin,  and  100 #M PMSF). 
The broken-cell suspension was centrifuged at 18,000 g for 30 rain. 
The iNOS activity in the supernatants was measured as L-arginine- 
and NADPH-dependent generation of NO2-. The assay was per- 
formed in 96-well microplates (Costar Corp.) by incubation of 200 
#g ofcytosol at 37~  for 18 h in 200/zl reaction buffer containing 
20 mM Tris/HC1 (pH 8), 4/zM BH4, 4/zM FAD, 5 mM DTT, 
2 mM NADPH, and protease inhibitors listed above. The reaction 
was initiated by adding 2 mM of L-arginine. Controls not receiving 
L-arginine were run in each case. In some experiments, different 
concentrations of PS or lysates from LPS-activated PEM pretreated 
with PS were preincubated with lysates of untreated LPS-activated 
macrophages for 30 rain before the addition of r-arginine. The reac- 
tions were terminated by addition of 2 U lactic dehydrogenase and 
5 #mol pyruvate to oxidate residual NADPH, which interferes with 
the Griess reaction. The final incubation mixtures were filtered by 
the use of the Ultrafree-MC Filter-30,000 NMWL (MiUipore Corp.) 
and the filtrates were mixed with the Griess reagent (1:1, vol/vol) 
for  NO2-  determination.  NO2-  in  the  control  incubation 
(without L-arginine)  was substracted from experimental values to 
determine t-arginine/NADPH-specific activity. NOS activity in 
macrophage cytosol was normalized according to the protein con- 
centration  of each experiment and expressed as nM of nitrites. 
Results 
Inhibitory Effect of DA-3 Cell Supernatants on the Production~Re- 
lease of NO2-  by PEM.  Macrophages  from normal  mice 
were  pretreated  for 24  h  with  different  concentrations  of 
supernatants from DA-3 cell cultures. The macrophage mono- 
layers were then washed twice and stimulated with 10 #g/ml 
of LPS for an additional  24 h.  After this  time period,  the 
macrophage culture supernatants  were subjected to analysis 
of NO2-,  a stable and nonenzymatic oxidative degradation 
product of NO (23). Fig. 1 shows that pretreatment of normal 
macrophages  with  DA-3  cell  supernatants  caused  a  dose- 
dependent  inhibition  of their  production  of NO2-.  50% 
DA-3  cell  supernatant  in  the  0.2-ml  macrophage cultures 
(1.5  x  105 cells) appeared to be the concentration necessary 
to achieve almost complete inhibition  of LPS-induced  NO, 
Downregulation of NO production/release by PEM was not 
attributable  to a  toxic effect of the DA-3 cell supernatants 
on the macrophages. Thus, the treated PEM released normal 
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Figure  1.  Inhibitory effect of DA-3 cell supernatants on normal PEM 
production ofNO2-. PEM from normal mice (1.5 x  10S/well) were in- 
cubated for 24 h with different concentrations of DA-3 supernatants or 
RPMI medium. Fresh medium with LPS (I0/zg/ml) was added to macro- 
phage cultures for an additional 24 h. The supernatants were collected 
and NO2- was measured as described in Materials and Methods. Values 
represent mean  _+  SE of triplicate wells from at least four separate ex- 
periments. 
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as measured by trypan blue exclusion. 
Initial Partial Characterization of the NO Inhibitory Factor(s) 
Present in the DA-3  Cell Supernatants.  As seen in Table  1, 
treatment  of DA-3 cell supernatants  at 37~  overnight or 
boiling at  100~  for 20 min did not impair its NO2-  in- 
hibitory property.  In addition,  exposure of the tumor cell 
supernatants to trypsin (10 mg/ml) or proteinase (0.5 mg/ml) 
did not diminish the observed inhibition  of nitrite produc- 
tion by PEM.  Likewise, DNase treatment  did not disrupt 
the bioactivity of the DA-3 cell cultures. These results sug- 
gest that the inhibitory factor(s) is a nonproteic molecule(s), 
most probably lipid or carbohydrate in nature. Therefore, it 
is unlikely that  the inhibitory molecule is one of the previ- 
ously reported macrophage NO-inhibitory factors of proteic 
nature, such as macrophage deactivating factor, TGF-~I,/32, 
and/~3  which have been purified from P815 mastocytoma 
cells (24).  Likewise, other NO inhibitors  of proteic nature 
such as epidermal growth factor (25),  IL-4 and IL-10 (26, 
27) and could not be the bioactive compound.  Indeed we 
Table  1.  Preliminary Characterization of the NO-Inhibitory 
Molecule(s) Produced by the DA-3 Mammary Tumor Cells 
Tumor supernatant  NO2- 
treatment  (nmol/1.5  ￿  105 macrophages) 
No supernatant  8.20  _+ 0.50 
Untreated  0.60  _+ 0.50 
Treated  at 37~ 
overnight  0.58  _  0.40 
Heated atl00~ 
(20 min)  0.51  +_ 0.38 
Trypsin  (10 mg/ml)  0.55  _+ 0.50 
Proteinase K 
(0.5 mg/ml)  0.60  _+ 0.50 
DNase (100 U/ml)  0.60  _+ 0.45 
Chloroform/methanol 
extraction  (2:1 vol/vol) 
0.19  mg/ml  6.98  _+ 0.50 
0.75  mg/ml  3.10  +_ 0.48 
1.0 mg/ml  0.48  +_ 0.50 
Filtered  (0.45  /~m) 
aqueous phase from 
chloroform/methanol 
extraction  (20%)  8.15  -+ 0.50 
PEM from normal mice (1.5 x  105 ceUs/0.2 ml cultures) were incubated 
for 24 h with medium (no tumor supernatants), untreated DA-3 super- 
natants (50%), or supematants treated as described  above. LPS (10/~g/ml) 
was added to macrophage cultures for an additional 24 h. The superna- 
tants from the maerophage cultures were collected, and NO2- was meas- 
ured as described  in Materials and Methods. Values represent mean + SE 
of triplicate wells from a representative experiment. 
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have found that the mammary tumor used in our studies does 
not produce either IL-4 or IL-10 (data not shown). We then 
performed a chloroform-methanol  extraction to investigate 
whether a lipidlike molecule was involved in the NO inhibi- 
tion observed. Both the chloroform-methanol-extracted ma- 
terials and the aqueous phase were tested as potential inhibi- 
tors of nitrite production by macrophages. Table 1 shows that 
40 #1 of the aqueous phase of the chloroform-methanol ex- 
traction from DA-3 supernatants had no inhibitory activity 
on the macrophages production  of NO2-.  Concentrations 
of the nonlipid aqueous phase >40/~1 (20%) were toxic to 
the macrophages. In sharp contrast were the results obtained 
when the chloroform-methanol-extracted  fraction was used 
as inhibitor.  A  slight  decrease in NO production  was ob- 
served with  0.19  mg/ml  extract.  Pretreatment  with  0.75 
mg/ml  of the lipid extract  reduced the levels  of NO pro- 
duced by normal PEM after LPS stimulation to one half of 
the levels observed in the untreated macrophage cultures. It 
is important to note that when the chloroform-methanol ex- 
tract was used at a concentration  of 1 mg/ml,  this extract 
displayed a bioactivity comparable to that of 100 #1 of the 
untreated DA-3 supernatant.  Since the NO-inhibitory mole- 
cule(s) can be recovered in the organic phase after extraction 
of the DA-3 cell supernatants with chloroform-methanol mix- 
tures,  the  possible extraction  of the  highly  polar  peptide 
platelet-derived growth factor, a reported inhibitor of mac- 
rophage  NO production  (28),  could be excluded. 
It should be emphasized that the viability of macrophages 
under these experimental conditions was not reduced, based 
upon trypan blue exclusion, morphological evaluation, and 
IL-1  and IL-6 production. 
Fractionation of the Organic Extract and Partial Characteriza- 
tion of the NO Inhibitory Factor(s) Present in the DA-3 Cell Su- 
pernatants.  The results of the preliminary  treatments  sug- 
gested  that  the  inhibitory  component  is  lipophilic,  since 
carbohydrates, proteins,  and peptides would be confined to 
the aqueous phase of the chloroform-methanol  extraction. 
A lipoprotein could not be the potential inhibitory material 
since the solvent used is known to denature these molecules. 
However, it was possible that a glycolipid could be the bio- 
active component since it is well known that some glycolipids, 
such as gangliosides,  are overexpressed and are shed by var- 
ious tumor cells (29-31). In addition, gangliosides have been 
shown to be capable of altering different parameters of the 
immune response (32, 33). To further analyze the nature of 
the  lipid-like  inhibitory  factor,  the  crude  lipids  were 
resuspended in chloroform and fractionated by silica gel column 
chromatography by sequential  elution with HPLC grade chlo- 
roform, acetone, and methanol (13). Thus, nonpolar neutral 
lipids were eluted first,  glycolipids which  have a medium 
polarity were next eluted, and phospholipids, which are the 
most polar of the lipids, were eluted last. Aliquots containing 
130 #g/ml  were prepared from each of 5-ml fractions ob- 
tained by this separation procedure and tested as possible in- 
hibitors in the Griess reaction using PEM from normal mice. 
As seen in Fig. 2, the NO2- inhibitory activity was confined 
to fractions 110 to 120, with a peak activity in fraction 114. 
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Figure  2.  Preliminary fractionation  of lipid extract from DA-3 cell su- 
pernatants  as a function of their capacity  to inhibit NO2-  production 
from PEM. The crude lipids were preliminary  fractionated  by a silica gel 
column chromatography eluted  as shown.  5-ml fraction  were collected. 
PEM from normal mice (1.5  x  105/well) were pretreated with 130 #g/ml 
of eluted  fractions  for 24 h.  The PEM were then washed  and activated 
with 10 #g/ml LPS for an additional  24 h. NO2- levels  were measured 
in the supernatants  of the macrophage  cultures  as described in Materials 
and Methods.  Values are the mean  _+  SE of triplicates cultures.  (Inset) A 
TLC of fraction 114 developed with chloroform-methanol-acetic acid-water 
(65:15:10:4, vol/vol), and visualized with the molybdenum blue reagent (15). 
polar, and that neutral lipids were not likely involved in the 
observed inhibition of NOz-.  To further characterize the 
material(s) present in fraction 114, TLC was employed. After 
the chromatographic development was completed, the chro- 
matogram was sprayed with either the molybdenum  blue re- 
agent which stains phospholipids (15) or with resorcinol  which 
reacts with glycolipids (14). The absence of glycolipids in 
fraction 114 was demonstrated by the tar-colored reaction ob- 
served in the resorcinol assay (data not shown). A positive 
reaction would have been a blue-violet color. However, when 
the TLC was sprayed with the molybdenum blue reagent, 
the characteristic blue color for phospholipids was observed, 
suggesting that phospholipids  were present in the fraction 
containing the bioactive property (inset  Fig. 2). 
Since fraction 114 may be comprised of more than a single 
component, it was further fractionated  on a second silica 
gel column chromatography, this time eluted with mixtures 
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Figure  4.  Effect of PLC digestion on the NO2- inhibitory activity of 
fraction 46. Fraction 46 was digested with/~ cereus PLC, and the product 
was extracted with diethyl ether.  The lipid extract  (160/~g/ml) and the 
untreated  fraction  46 (160/xg/ml) were assayed for NO2- inhibition in 
LPS (10/xg/ml)-activated PEM as described in Materials  and Methods. 
Data are expressed as the mean _+ SE of triplicate cultures of four different 
experiments. 
graphic  separation  showed the highest inhibitory activity 
in fraction  46  (Fig. 3).  When a TLC of fraction  46 was 
performed it gave evidence of the presence of a single molyb- 
denum positive spot with retention factor (R  0  =  0.75 (Fig. 
3, right inset). HPLC analysis of fraction 46 showed two peaks 
with retention time (Rt) of 1.81 and 3.51 min (Fig. 3, le~ 
inset). The bioactive analysis of these peaks demonstrated that 
they corresponded  to chloroform and to the putative  NO 
inhibitor, respectively (data not shown). In previous studies, 
Ladisch et al. (29, 32), Hakomori and collaborators (30, 34), 
and other investigators (31, 33, 35) have provided evidence 
that traces of glycolipids from tumor cells have the capacity 
to act on immune effector cells and alter their functions. To 
obtain  further assurance of the phospholipid  nature of the 
inhibitory material, a digestion of the bioactive factor with 
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Figure  3.  Isolation  of a NO inhibitor from the metha- 
nolic fraction collected during the preliminary fractionation 
of the lipids extracted from DA-3 cell supernatants. The metha- 
nolic fraction  from the previous fractionation  of the crude 
lipids was concentrated, resuspended in chloroform-methanol 
(95:5), and charged on a silica gel column. The column was 
successively  eluted with chloroform-methanol  mixtures as in- 
dicated.  5-ml fractions were collected and assayed for their 
NO2- inhibitory activity on PEM as described in Materials 
and Methods.  Values are the mean  _+  SE of triplicate  cul- 
tures. (Right inset) TLC of fraction 46 developed and visual- 
ized as in Fig.  2.  (LeJ~ inset)  HPLC analysis of fraction  46 
using a 3.9 mm  x  30 cm/zPorasil  TM column with a mobile 
phase  of  acetonitrile-methanol-85%  phosphoric  acid 
(390:5:4.5,  vol/vol) flowing at  2.0 ml/min. UV detection 
was monitored at 205 nm (17). 
950  Nitric Oxide Inhibitor Produced  by Tumor Cells Digestion of Fraction 46 with PLC.  Since our results sug- 
gested that the NO inhibitor is a phospholipid, we subjected 
the inhibitory fraction 46 to enzymatic degradation with PLC 
in order to provide further confirmation of the phospholipid 
nature of this factor (18). After the reaction mixture was shaken 
at room temperature for 2 h, it was extracted three times 
with 4-ml portions of diethyl ether. This ether extract was 
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Figure 5.  FAB mass spectra of the purified  active  fraction  46. (.4) Nega- 
tive ion mode  spectrum  shows  peaks at m/z 788, 814, and 834 representing 
the [M-H]  - ions  of three PS molecular  species with total acyl group com- 
positions 36:1 (carbon  chain  length/double  bonds), 38:2, and hydroxy  38:0, 
respectively. Corresponding fragment ions at m/z 701, 727, and 747 
([M-H-87] -) are diagnostic  for the loss of the serine residue  from  the head 
group. Low mass fragments  at m/z 137, 153, 184, and 224 support the 
assignment as PS molecular  species (6, 7). Carboxylate  anions at m/z 281 
(18:1), 283 (18:0), and 327, weak, (h 20:0) indicate  that the fatty  acyl  groups 
in the two major  PS molecular  species are likely  18:0/18:1 (m/z 788) and 
18:0/hydroxy  20:0. This  conclusion  was supported  by product  ion spectra 
of the [M-H]- and [M-H-87]- ions of these two molecular  species (data 
not shown). (B) Positive  ion mode spectrum displays [M+H] + peaks for 
the three PS molecular  species detected  in the negative  mode analysis  at 
m/z 790, 816, and 836, together  with expected  fragments  formed  by loss 
of the head group, [M + H- 85] +, at m/z 605, 631, and 651. Minor  peaks 
representing the IM+H] + ions of traces of PC molecular species from 
an adjacent  inactive  fraction  can also  be seen  (V). (*) Glycerol  matrix  peaks. 
as solvent and then treated with iodine vapors to localize the 
degradation products from the enzymatic reaction. When 
a parallel TLC of the ether extract was sprayed with the mo- 
lybdenum blue reagent, the blue coloration of phospholipids 
was not visualized, indicating that fraction 46 was completely 
degraded by PLC (data not shown). The products from the 
enzymatic digestion were scratched from the nonsprayed TIE:, 
deabsorbed with methanol, and the methanol solution was 
dried under nitrogen before it was tested for inhibition of 
macrophage production of NO. In Fig. 4, it can be seen that 
the products from the digestion of  fraction 46 with PLC had 
lost their bioactivity, confirming that a phospholipid is respon- 
sible for the nitrite inhibition caused by the supernatants of 
the DA-3  tumor cells cultures. 
Analysis of Fraction 46 by FAB-MS.  To elucidate the mo- 
lecular structure of the phospholipid responsible for the in- 
hibition of nitrite production, fraction 46 was subjected to 
FAB-MS in the positive and negative modes. The results from 
the negative ion FAB mass spectrum of the purified active 
fraction 46 are shown in Fig. 5 A, where two predominant 
high mass peaks at mass-to-charge ratio (m/z) 788 and 834 
and a minor peak at m/z 814 are readily apparent. Diagnostic 
fragments in the spectrum at m/z 137, 153, 184, 224,  701, 
727, and 747 suggested that the three high mass ions repre- 
sent the [M-H]-  ions of three PS  molecular species with 
total acyl group compositions of 36:1 (carbon number/double 
bonds) and hydroxy 38:0 and 38:2,  respectively  (6, 7). Car- 
boxylate anions at m/z 281, 283,  and 327 (weak) indicated 
that the fatty acyl groups in the two major molecular species 
were likely 18:0/18:1 (m/z 788) and 18:0/hydroxy 20:0 (m/z 
834).  This was supported by B/E linked scan (production 
ion) spectra of the two major [M-HI -  ions and their corre- 
sponding  [M-H-87]-  fragments by FAB  coUisionally  in- 
duced dissociation-tandem MS, which confirmed the proposed 
acyl groups compositions and further indicated that the oleoyl 
(18:1) and hydroxyeicosanoyl  (h 20:0) groups were at the sn-2 
positions (7, 36) in the two major components of PS (data 
not shown). GC-MS analysis after transesterification of frac- 
tion 46 with NaOMe in MeOH and subsequent trimethyl- 
silyation of the liberated fatty acids revealed that the hydroxyl 
group of the hydroxy 20 carbon acyl group was in the c~ po- 
sition (M + at m/z 414,  M-59 at m/z 355,  base  peak). 
The positive ion mode FAB spectrum of the fraction 46 
is presented in Fig.  5 B  (*,  matrix peaks).  The expected 
[M+H] + ions for the PS molecular species were observed, 
along with the corresponding diagnostic fragments for PS 
at [M + H- 185] + (7).  Minor [M + H] + peaks  representing 
traces of PC molecular species from an adjacent inactive frac- 
tion were also observed  at m/z 760,  788,  and 806 (Y). PG 
and SM were also separated in the inactive fractions and charac- 
terized by FAB-MS. These studies strongly suggest that PS 
is the NO inhibitory molecule derived from the mammary 
tumor cells, and that the minor phospholipids, i.e., SM and 
PG, and the more abundant PC,  are not playing a crucial 
role in this modulatory activity. In both the positive and nega- 
tive ion mode FAB spectra of fraction 46, ions representative 
for glycolipids were absent. The role played by acyl groups, 
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Figure  6.  Effect  of phosphatidyl choline (PC), phosphatidyl glycerol 
(PG), sphingomyelin  (SM), and phosphatidyl serine (PS) on the LPS-induced 
macrophage production of NO2-. PEM were incubated for 24 h with 
PC, PG, SM, or PS at the concentrations indicated. After this time, the 
macrophages were washed and incubated for an additional 24 h with fresh 
medium containing LPS (10 #g/ml). The supernatants of the macrophage 
cultures were collected and NO2- was measured as described in Materials 
and Methods. Each value is the mean •  SE of three replicates from four 
different experiments. 
carbons numbers, unsaturation,  and the presence and/or lo- 
cation of hydroxyl groups at the snl or sn2 positions of PS 
is  at  present  under  investigation  to  determine  structure- 
activity relationships. 
To unequivocally confirm these results, we purchased com- 
mercially available PS, PC, PG, and SM. We then used these 
standard compounds as potential NO inhibitors in the assay 
for production of nitrites by PEM from normal mice. As seen 
in Fig. 6, PC,  PG, and SM ranging from 30 to 160 #g/ml 
did not affect the levels of nitrite produced by the PEM from 
normal mice stimulated  with LPS.  In sharp contrast  were 
the results  obtained  with  PS which had a dose-dependent 
inhibitory activity on the production of NO by LPS-stimulated 
PEM,  which resulted in a total abrogation of NO produc- 
tion at  concentrations  of 160 #g/ml. 
Comparison between NO Production and Cytotoxicity of  PEM. 
To ascertain that the inhibition of nitrite production brought 
about by the presence of PS correlates with the loss of cyto- 
toxic potential previously seen in PEM from tumor-bearing 
mice, experiments were performed to concomitantly analyze 
these two parameters in cultures of PEM from normal mice 
treated with  the purified fraction 46 or with PS from two 
commercially available  sources.  In our experiments  we in- 
cluded  NGMMA  as  a  control  for  the  inhibition  of NO 
production and cytotoxicity of macrophages since this  is a 
known NO inhibitor whose actions result in the loss of cyto- 
toxic activity by macrophages (4, 37). NGMMA was added 
together with the LPS to the PEM,  since it has been shown 
Table  2.  Correlation of N02-  Production and Cytotoxicity of PEM from Normal Mice Pretreated with Various Species of PS 
Inhibitor  Dose  NO2-(nmol/1.5  x  10  s cells)*  Percent cytotoxicity* 
None  -  7.64  _+  0.4  48.4  _+  2.0 
500/.tM  0.12  _+  0.4  12.7  _+  2.0 
NCMMA  s  50 #M  3.20  _+  0.5  30.4  _+  2.1 
5 #M  7.25  _+  0.5  46.4  +  1.0 
160/zg/ml  0.43  _+ 0.5  17.0  _+  1.1 
Fraction 46 II  130/zg/ml  3.20  _+  0.2  28.3  _+  1.7 
30/zg/ml  5.47  _+  0.4  37.3  _+  1.0 
160 #g/ml  0.49  +  0.5  18.2  _+  2.2 
Bovine  130 #g/ml  3.16  _+ 0.5  29.5  _+  1.1 
brain  PS II  30 ~g/rnl  5.77  +  0.5  38.0  _+ 2.0 
160 #g/ml  0,36  _+  0.5  16.3  _+  1.5 
PS (18:0/18:1)11  130 #g/ml  2.90  _+  0.5  26.8  +  2.1 
30 #g/ml  6.80  +  0.3  39.6  +  2.4 
* NO2- levels were measured in the supernatants of the macrophage cultures as described in Materials and Methods. Values are the mean _  SE 
of triplicate cultures. 
After 24 h of stimulation with LPS, macrophages were washed twice and cocultured for 18 h with DA-3 targets in fresh medium (104 cells/well). 
Percent specific cytotoxicity was determined by the MTT method (19) as described in Materials and Methods. Values are the mean _+ SE of triplicate 
cultures from a representative experiment. 
S PEM from normal mice (1.5  x  10  s cells/0.2 ml) were cocultured for 24 h with the indicated concentrations of NCMMA and LPS (10/zg/ml). 
If PEM from normal mice (1.5  x  10  s cells/0.2 ml) were incubated for 24 h with the indicated concentrations of the inhibitors. Fresh medium with 
LPS (10/~g/ml)  was added to macrophage cultures for an additional 24 h. 
952  Nitric Oxide Inhibitor Produced by Tumor Cells that  this inhibitor  does not function unless it is cocultured 
with  macrophages  in  the presence of LPS (37). 
PEM were pretreated with either fraction 46, or commer- 
cial PS for 24 h,  washed  twice,  and  then  stimulated with 
LPS (10/~g/ml)  for an additional 24 h.  After this time, the 
supernatants  (100 #1) were collected and mixed with 100/~1 
of the Griess reagent for the quantitation  of NO2-  produc- 
tion by macrophages.  DA-3 target cells (104) were added to 
the macrophage cultures, and cocultured with fresh medium 
for 18 h. Table 2 shows that the NO production by macro- 
phages decreases in proportion with increasing  concentrations 
of fraction  46,  and that  this inhibition  of NO production 
parallels a decrease in macrophage cytotoxicity. Similar results 
were found when PEM were pretreated with either the crude 
PS extract from bovine brain or with the commercially avail- 
able major molecular species of fraction 46, PS (18:0/18:1). 
These results strongly indicate that NO is the crucial mole- 
cule responsible for the lysis of DA-3 mammary tumor cells 
by macrophages. Furthermore, these data unequivocally char- 
acterize PS as the NO inhibitor produced by the DA-3 tumor 
cells. 
Screening of Supernatants  from Tumor Cell Lines for their Ca- 
pacity to Inhibit NO Production/Release in Normal PEM.  To 
investigate whether supernatants from other tumor cell types 
are capable of inhibiting the production and/or release of NO, 
we tested the supernatants  of a panel of cell lines known to 
have various levels of PS present on their surfaces (10),  i.e., 
A375 melanoma with  75  _+  10 ng  PS/104  cells,  the  squa- 
mous cell carcinoma A431 with 39  _+  6 ng PS/104 cells, and 
the normal epidermal keratinocyte NHEK with  11  +  2 ng 
PS/104 cells. None of the supernatants of these cell lines had 
NO inhibitory properties, a result that could be potentially 
due to the lack of secretion of PS from the cell surface into 
the culture medium.  In addition,  we tested two other rou- 
tine mammary adenocarcinoma cell lines for NO inhibitory 
activity. Whereas no NO inhibition was obtained with the 
nonmetastatic  168 cells,  a 10% inhibition  of NO could be 
detected when 50% supernatants  of the 410.4 metastatic  mam- 
mary tumor cells were used as pretreatment of normal PEM 
before LPS stimulation.  Studies are planned to measure ac- 
tual levels of PS released in the culture medium by the different 
tumor  cells,  including  the DA-3  mammary  tumor  cells. 
Evaluation of Biological Functions of PS-treated PEM.  We 
next examined  the effects of PS on the viability and func- 
tionality of PEM, by studying a number of activities of the 
macrophage functional repertoire, namely phagocytosis, the 
reduction of MTT, superoxide production, total protein con- 
tent  from  lysates,  and  the production  of IL-lol  and  IL-6. 
Phagocytosis of particles by macrophages result in an increase 
of  oxygen  consumption  with  subsequent  production  of 
oxygen-derived radicals  (38), a NADPH-utilizing pathway, 
as is  NO  production  (39).  Accordingly,  when  PEM were 
pretreated with PS and then activated with LPS, they phago- 
cytosed  25  _+  5  zymosan  particles/cell,  whereas  non- 
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Figure  7.  Phagocytosis  ofzymo- 
san particles by PS-treated PEM. 
Macrophages were nontreated (A) 
or treated (C) with PS, stimulated 
with 10/zg/ml LPS, and cultured 
with zymosan  particles  as indicated 
in Materials  and Methods. The cells 
were then examined on an inverted 
Nikon microscope  equipped  with a 
laser-scanning device. Transmitted 
light images  from the laser-scanning 
confocal microscope  (A and C) are 
paired  with  the  corresponding 
refracted light image of the same 
field (B and D). Images are of 0.6- 
/.tm-thick optical section. PS-pretreated PEM gave an average of 19  +  5 phagocytosed 
particles/cell.  A  microscope observation  of the  phagocytic 
activity of PS-pretreated PEM can be seen in Fig.  7, where 
the confocal laser  scanning  image produced  with  refracted 
light demonstrates  the presence of slightly higher numbers 
of particles within  these cells  as compared to the particles 
ingested by untreated PEM.  These results correlate with the 
slightly higher O2-  production by PS-pretreatment PEM as 
compared to the levels produced by the untreated control PEM 
(Table 3). These data indicate the integrity of the NADPH- 
O2 system in PS-pretreated PEM.  Likewise, PS-treated PEM 
preserve their capacity to reduce MTT, which reflects the op- 
timal response of the mitochondrial dehydrogenases (19). Ad- 
ditional evaluations showed that the level of total protein con- 
centration of adherent cells was not affected in PS-pretreated, 
LPS-activated PEM as compared with the untreated control 
(Table 3). Similarly, the amounts of IL-lot and IL-6 produced 
by untreated and experimental PEM did not show significant 
differences.  Thus,  the results  presented  in  Table 3  demon- 
strate that the viability and functionality ofPS-pretreated PEM 
has not been impaired by treatment with the phospholipid. 
Effects of PS on the Production of NO by PEM Activted with 
Nonlipid Stimulators.  To rule out the possible lipid-lipid in- 
teraction of PS and LPS as a possible cause of the downregu- 
lation of NO  production by PS-pretreated PEM,  we exam- 
ined  the  effect of nonlipid  stimulators  of macrophages  as 
inducers of NO production. As shown in Table 4, 160 #g/ml 
Table  3.  Evaluation of Viability and Intact Functionality of 
PS-treated PEM 
Parameter assayed  Untreated  PEM  PS-treated  PEM 
Table  4.  Effects of PS on the Production of NOz-  by PEM 
Activated with LPS and Nonlipid Stimulators 
Activator  Control PEM  PS-treated PEM 
LPS  (10/~g/ml)  7.64  +  0.2  0.36  _+  0.1 
IFN-3' (500  U/ml)  0.7  _+ 0.1  0.06  +_  0.01 
SEB  (300  /~g/ml)  0.52  _+  0.1  0.04  _+ 0.01 
Normal PEM (1.5  x  10  s cells/0.2 ml) were cultured with or without 
(control PEM) I60/xg/ml PS for 24 h. The cells were then washed and 
cultured with flesh medium supplemented with activators as shown above 
for a period of 18 h. Nitrite was measured as described in Materials and 
Methods.  Values are the mean _+ SE of triplicate cultures from three 
representative experiments. 
PS virtually abolished the capacity of PEM to produce NO 
upon  activation  with  either  LPS  (10/~g/ml),  IFN-3,  (500 
U/ml), or SEB (300 #g/ml).  These results suggest that the 
inhibitory activity of PS on PEM is not due to a direct inter- 
action between two molecules of lipid nature since the same 
results were obtained when nonlipid stimulators were used. 
Kinetics  of the  Inhibitory  Activity  of PS  on  LPS-activated 
PEM.  In Fig. 8, the kinetics of the NO inhibitory activity 
of PS on PEM  is depicted,  illustrating  that  at least 2  h  of 
PS pretreatment  are needed  to visualize  a  decrease  of NO 
production  by LPS-activated PEM.  Preincubation  of PEM 
with PS for 2, 4, 6, or 8 h resulted in a profound inhibition 
of their potential to produce/release NO,  and this was fur- 
ther accentuated in PEM cultures that were pretreated with 
PS for 18 h.  Addition  of PS to macrophage cultures  at the 
02-  production* 
(nmol/1.5  x  l0  s cells)  1.55  +  0.03  1.89  _+  0.03 
MitochondriaP 
dehydrogenases  (OD)  0.820  _+  0.03  0.911  _+ 0.07 
Total protein levetsS 
(/~g/ml)  501  _+  46  497  _+  44 
IL-l-c~(pg/ml)JI  300  +  66  375  _+  15 
IL-6 (pg/ml)ll  18,285  ~-  3,000  18,309  _+  3,805 
PEM from normal mice (1.5  x  10  s cells~0.2 m]) were cultured for 24 h 
by  themselves or  in  the  presence of 160  #g/ml  PS,  washed  with 
RPMI-1640, and then activated with 10 #g/ml LPS as indicated in Materi- 
als and Methods. All experiments are the mean  +  SE of triplicate cul- 
tures from three representative experiments. 
* Superoxide (O2-) production was assayed by the method of Pick and 
Mizel (20). Experimental PEM were incubated for 1 h with 100/~1 of 
160/~M ferricytochrome c in HBSS. The absorbance was measured at 
550 nm. 
t The optical density of formazan  salt produced  as a consequence of 
MTT reduction (19), was measured at 570 nm. 
S The protein assay was performed following the method of Lowry et 
al.  (21). 
I[ IL-l-ot and IL-6 were measured with commercially available ELISA 
kits. 
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Figure  8.  Effect  of time of PS addition on the LPS activation of PEM 
to produce NO. PS (160 #g/ml) was added to macrophage cultures (1.5 
x  10s/0.2 ml) before (negative numbers), at the same time (zero), or after 
(positive numbers) activation with 10 #g/ml LPS as indicated. After 18 h 
of activation, NO2- was measured as described in Materials and Methods. 
Only cultures preincubated with PS (negative numbers) were washed with 
RPMI before the addition of LPS. The values are the mean _+ SE of tripli- 
cate cultures from three independent experiments. 
954  Nitric  Oxide Inhibitor  Produced by Tumor Cells time of stimulation (zero time) did not interfere with their 
normal production/release of NO. Treatment of PEM with 
PS after 2, 4, or 6 h of activation with LPS, produced a small 
increase in the production of NO. Therefore, a pretreatment 
appears to be required in order to observe the inhibitory ac- 
tivity of PS in the production and/or release  of NO. 
Reversibility of the Inhibition of NO Production by PS-pretreated 
PEM.  As previously shown,  maximal NO inhibitory ac- 
tivity of PS (95%) is observed when PEM are pretreated with 
PS for 24 h, washed with RPMI-1640, and immediately in- 
cubated for 18 h  with medium containing 10 gg/ml LPS. 
However, if the addition of LPS to macrophage cultures is 
delayed for a period of 24 or 48 h  after removal of PS, the 
inhibition of NO declines to 67 and 38%, respectively (Fig. 
9). These results indicate the partial reversibility of the in- 
hibitory activity of PS and further substantiate the intact via- 
bility and functionality of PEM pretreated with PS. 
iNOS Activity.  In further studies we evaluated whether 
PS could affect the activity of iNOS. PEM were incubated 
for 24 h with medium supplemented or not (control) with 
160/~g/ml PS. After completion of the incubation time, the 
macrophage layers were washed and cultured for an additional 
18 h with medium containing 10 gg/ml LPS. The iNOS ac- 
tivity of PEM cytosols (200 gg of protein) in the presence 
of defined cofactors (FAD, NADPH,  BH4 and DTT) was 
determined, iNOS activity was not detectable in the cytosol 
of macrophages preincubated with PS (Table 5). However, 
control macrophages, not preincubated with PS, showed 10.66 
+  0.3 nmol of NO2-  as iNOS activity. Table 5 also illus- 
trates that if before the addition of t-arginine to the reaction 
mixture, the iNOS-active cytosol is preincubated for 30 min 
with either 5-20/~g PS or 10-30/zg of the cytosol of LPS- 
Table  5.  Effects of PS and the Cytosol of Activated PEM 
Pretreated with PS on iNOS Activity 
Cytosol from 
activated PEM 
Cytosol from  pretreated 
activated PEM  with PS  PS  N02- 
~g  I~g  I~g  nmol 
200  --  --  10.66  +  0.3 
--  200  --  0.09  +_  0.2 
200  10  --  11.12  +  0.5 
200  20  --  9.57  +  0.5 
200  30  --  8.50  +  0.2 
200  -  5  9.00  +  0.5 
200  -  10  9.20  +  0.5 
200  -  20  9.40  _  0.5 
LPS-activated macrophage cytosol (200/xg) from normal PEM treated 
or untreated with PS were assayed for iNOS activity  in the presence  of 
defined cofactors as described  in Materials and Methods. In some wells, 
cytosol from  LPS-activated  normal PEM (200 pg) was incubated for 30 
min either with PS or cytosol from activated PEM pretreated with PS 
before the addition of L-arginine to the reaction mixture. Nitrite levels 
were normalized  according  to the protein  concentration  of each experimen- 
tal assay. Values are the mean + SE of duplicate cultures from  three in- 
dependent experiments. 
activated PEM pretreated with PS, the capacity of the active 
cytosol to produce NO remains unaffected. Preincubations 
of 10 and 20 rain gave similar results (data not shown). These 
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Figure  9.  Reversibility  of the inhibition  of NO production  by PS-treated 
PEM. Normal PEM (1.5 x  10s/0.2  ml) were cultured for 24 h with or 
without (control)  160 #g/ml PS. The cell  monolayers  were  washed twice 
with RPMI, added fresh culture medium, and activated for 18 h with 
10/xg/ml LPS. The addition of LPS to cell cultures was done either im- 
mediately (zero time) or delayed  for 24 or 48 h. NO2- in cell cultures 
was measured  as described  in Materials and Methods. Data are expressed 
as the mean +_ SE of  triplicate  cultures  from  three  representative  experiments. 
Discussion 
Activated macrophages play an important role in host- 
defense mechanisms (40, 41), against cancer (42), and against 
infections (43). The acquisition of the activated state is a com- 
plex process that can be achieved under appropriate stimula- 
tion of macrophages with naturally occurring substances or 
with synthetic agents (44). LPS is a well-known activating 
agent that can trigger the macrophage cytotoxicity on tumor 
targets either alone or in combination with lymphokines (45, 
46). Although tumor cells are heterogeneous with regard to 
many characteristics (47), they seem to share susceptibility 
to destruction by activated macrophages. In this regard, Hibbs 
et al. (4, 23, 48) have shown that the crucial agent that directly 
contributes to the tumoricidal activity of  macrophages is NO, 
a freely diffusible,  short-lived,  and  highly toxic molecule. 
Similar results reported by other investigators (12, 49) sup- 
port this concept. Therefore, the integrity of the circuit of 
macrophage activation to kill tumor cells must be maintained 
in order to prevent the subversion of the host immunity by 
tumors. However, during neoplasm development, tumor cells 
either directly or indirectly appear to impair one or more 
steps of this complex machinery as a mechanism to evade their 
destruction by activated macrophages (1, 50). In the present 
955  Calder6n  et al. study, we provide evidence that tumor-derived PS could be 
one of such immune regulatory agents with the capacity to 
protect tumor cells from destruction via the impairment  of 
NO production  by macrophages. 
Various reports have demonstrated  that PS possesses im- 
munomodulating  properties in vivo or in vitro,  including 
the enhancement of the ability of epidermal Langerhans cells 
to induce contact hypersensitivity (51), the augmentation of 
the binding of peptides to purified class II MHC molecules 
(52),  and the inhibition  of DNA synthesis in lymphocytes 
(53). Furthermore, and more pertinent to our studies, PS has 
been found to inhibit the lymphokine-induced macrophage 
microbicidal activity against Leishmania major (54). Thus, we 
could speculate that  this inhibition  of the microbicidal ac- 
tivity of the macrophages  could be mediated by the NO- 
inhibitory property of PS.  This conjecture is supported by 
the publications ofLiew et al. (55) and Green et al. (56) who 
coincide in pointing out that the production of NO is a cru- 
cial event in macrophage  killing  of L.  major. As a whole, 
these observations suggest that the inhibition of NO produc- 
tion in macrophages by PS represent  an important  regula- 
tory mechanism applicable to situations where macrophage 
cytotoxicity is of relevance. 
During  the  last  20  yr,  compelling  evidence  has  been 
presented that lipids of biological membranes are asymmetri- 
cally distributed, providing in this way, a molecular basis for 
their functional diversity (57, 58). This functional asymmetry 
is best exemplified by the frequent preservation of PS within 
the inner  leaflet  of cells (59,  60).  Many investigators  have 
shown that failure of cells to keep this rule is usually associated 
with their recognition by mononuclear phagocytes, as is the 
case with tickled cells or resealed red cell ghosts (61-64). Re- 
cently, the asymmetric distribution of PS in cell membranes 
is gaining increasing attention.  The report of Utsugi et al. 
(10) is of particular interest. These authors noted that when 
activated human blood monocytes bind to tumor cells that 
overexpress PS in  their  outer membrane leaflet,  target  cell 
destruction ensues.  In contrast, normal keratinocytes which 
externally express PS in comparatively lower amounts than 
those in tumor cells,  are not bound or lysed by the mono- 
cytes. In a recent review,  Savill et al. (65) have suggested the 
presence of at least three classes of receptors in phagocytes 
for the recognition of apoptotic cells, which include receptors 
for lectin, thrombosponclin, and PS. These observations, to- 
gether with our findings,  suggest that  tumor cells that ex- 
press PS in their outer leaflet could be targeted to be lysed 
by macrophages. However, the overexpression and shedding 
of PS by the tumor cells could result in the blockage of the 
putative PS receptors present in the macrophages. By altering 
this tightly controlled process, tumor cells may evade the host 
defenses provided by the macrophages.  The ubiquity of PS 
in cell membranes from different tissues, together with its 
NO-inhibitory property, indicate that this phospholipid may 
be one of the long sought-after and hitherto uncharacterized 
molecules responsible for regulating the physiological levels 
of NO. 
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